166 related articles for article (PubMed ID: 34647607)
1. PEDF relieves kidney injury in type 2 diabetic nephropathy mice by reducing macrophage infiltration.
Li L; Zhang L; Chen D; Yu K; Gan H; Yang G
Endokrynol Pol; 2021; 72(6):643-651. PubMed ID: 34647607
[TBL] [Abstract][Full Text] [Related]
2. Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.
Awad AS; Gao T; Gvritishvili A; You H; Liu Y; Cooper TK; Reeves WB; Tombran-Tink J
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F891-900. PubMed ID: 23884140
[TBL] [Abstract][Full Text] [Related]
3. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
Awad AS; You H; Gao T; Gvritishvili A; Cooper TK; Tombran-Tink J
PLoS One; 2015; 10(7):e0133777. PubMed ID: 26207369
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.
Liu Y; Leo LF; McGregor C; Grivitishvili A; Barnstable CJ; Tombran-Tink J
Mol Med; 2012 Dec; 18(1):1387-401. PubMed ID: 23019073
[TBL] [Abstract][Full Text] [Related]
8. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
9. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
10. [The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy].
Zhang W; Duan HT; Chen S; Wang YX; Kong JH; Dong M; Bi X; Song J
Zhonghua Yan Ke Za Zhi; 2017 Jul; 53(7):540-547. PubMed ID: 28728289
[No Abstract] [Full Text] [Related]
11. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
He X; Cheng R; Park K; Benyajati S; Moiseyev G; Sun C; Olson LE; Yang Y; Eby BK; Lau K; Ma JX
Kidney Int; 2017 Mar; 91(3):642-657. PubMed ID: 27914705
[TBL] [Abstract][Full Text] [Related]
12. The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus.
Tabur S; Oğuz E; Sabuncu T; Korkmaz H; Çelik H
Clin Exp Hypertens; 2015; 37(3):177-83. PubMed ID: 25050869
[TBL] [Abstract][Full Text] [Related]
13. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy in Egyptian patients with type 2 diabetes mellitus.
Fayed A; Rabiee A; El-Saadany O; Shaban M; Hesham D; Elghobary H; Hammad H; Fatthy M
Saudi J Kidney Dis Transpl; 2021; 32(5):1340-1347. PubMed ID: 35532703
[TBL] [Abstract][Full Text] [Related]
14. Recovery of Corneal Sensitivity and Increase in Nerve Density and Wound Healing in Diabetic Mice After PEDF Plus DHA Treatment.
He J; Pham TL; Kakazu A; Bazan HEP
Diabetes; 2017 Sep; 66(9):2511-2520. PubMed ID: 28592408
[TBL] [Abstract][Full Text] [Related]
15. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
[TBL] [Abstract][Full Text] [Related]
16. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
Li F; Chen Y; Li Y; Huang M; Zhao W
Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
[TBL] [Abstract][Full Text] [Related]
17. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
Ndisang JF; Jadhav A
Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713
[TBL] [Abstract][Full Text] [Related]
18. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex.
Che D; Fang Z; Yan L; Du J; Li F; Xie J; Feng J; Yin P; Qi W; Yang Z; Ma J; Yang X; Gao G; Zhou T
Diabetologia; 2020 Sep; 63(9):1857-1871. PubMed ID: 32377760
[TBL] [Abstract][Full Text] [Related]
19. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.
Jenkins AJ; Zhang SX; Rowley KG; Karschimkus CS; Nelson CL; Chung JS; O'Neal DN; Januszewski AS; Croft KD; Mori TA; Dragicevic G; Harper CA; Best JD; Lyons TJ; Ma JX
Diabet Med; 2007 Dec; 24(12):1345-51. PubMed ID: 17971181
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of serum pigment epithelium-derived factor aggravate proteinuria via induction of podocyte actin rearrangement.
Huang N; Zhang X; Jiang Y; Mei H; Zhang L; Zhang Q; Hu J; Chen B
Int Urol Nephrol; 2019 Feb; 51(2):359-367. PubMed ID: 30536192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
